Page last updated: 2024-09-04

dansylethylenediamine and purvalanol b

dansylethylenediamine has been researched along with purvalanol b in 1 studies

Compound Research Comparison

Studies
(dansylethylenediamine)
Trials
(dansylethylenediamine)
Recent Studies (post-2010)
(dansylethylenediamine)
Studies
(purvalanol b)
Trials
(purvalanol b)
Recent Studies (post-2010) (purvalanol b)
110331013

Protein Interaction Comparison

ProteinTaxonomydansylethylenediamine (IC50)purvalanol b (IC50)
G2/mitotic-specific cyclin-B2Homo sapiens (human)0.006
G1/S-specific cyclin-E2Homo sapiens (human)0.009
Cyclin-dependent kinase 1Saccharomyces cerevisiae S288C1.2
Insulin receptorHomo sapiens (human)2.2
Tyrosine-protein kinase LckHomo sapiens (human)0.006
Cyclin-dependent kinase 1Homo sapiens (human)0.006
G2/mitotic-specific cyclin-B1Homo sapiens (human)0.006
G2/mitotic-specific cyclin-BMarthasterias glacialis (spiny starfish)0.006
cAMP-dependent protein kinase catalytic subunit alphaHomo sapiens (human)3.8
Cyclin-A2Homo sapiens (human)0.006
cAMP-dependent protein kinase catalytic subunit gammaHomo sapiens (human)3.8
cAMP-dependent protein kinase catalytic subunit betaHomo sapiens (human)3.8
G1/S-specific cyclin-E1Homo sapiens (human)0.009
Cyclin-dependent kinase 2Homo sapiens (human)0.0072
Mitogen-activated protein kinase 3 Homo sapiens (human)3.3165
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.006
Cyclin-A1Homo sapiens (human)0.006
Cyclin-dependent-like kinase 5 Homo sapiens (human)0.006
Cyclin-dependent kinase 5 activator 1Homo sapiens (human)0.006
Cdc2Patiria pectinifera0.15
G2/mitotic-specific cyclin-B3Homo sapiens (human)0.006
Cyclin-dependent kinase 1Oryzias latipes (Japanese medaka)0.006

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, ML; Dakshanamurthy, S; Deb, TB; Grindrod, SC; Paige, M; Yang, Y; Yenugonda, VM1

Other Studies

1 other study(ies) available for dansylethylenediamine and purvalanol b

ArticleYear
Fluorescent cyclin-dependent kinase inhibitors block the proliferation of human breast cancer cells.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Adenine; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinases; Dansyl Compounds; Female; Fluorescent Dyes; Humans; Protein Kinase Inhibitors

2011